A forensic read on DuPont De Nemours, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
-0.7
Distress distance
Clean
Earnings quality
4
Forensic signals
-4.2%
ROE
1.9%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
DuPont De Nemours, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -0.7, placing it in the Distress zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
1.3%
FY2025
Return on invested capital.Return on invested capital is 1.3% in the latest fiscal year and steady across FY2023–FY2025, inside a 1.1-point range. After-tax operating profit was $92M in FY2023 and $333M in FY2025. The capital base behind it came down -25% across FY2023–FY2025, from $33.1B to $24.9B, so this return is struck on a smaller base than it started on. FY2023's operating profit carried a $668M goodwill write-off and a $99M restructuring charge that took about 1.8 points off that year's return, and FY2025's carried a $151M restructuring charge that took about 0.4 points off the latest; so, net of each other, the two charges add about 1.4 points to the +1.0-point change across FY2023–FY2025. FY2024's operating profit carried a $57M restructuring charge that alone took about 0.1 points off that year's return; FY2024 sits between the two ends of FY2023–FY2025, so the charge shapes the path between them without moving the change across it. A non-cash write-down lowers the reported return in the year it lands.
263% of FCF
FY2025
Shareholder returns.Returned $597M to shareholders (buybacks + dividends) in FY2025 — 263% of free cash flow. That is $370M (163%) more than free cash flow covered, and more than operating cash flow as well. It came out of the balance sheet's own liquid holdings, not new debt: cash fell $1.1B over FY2025, while total debt fell $4.0B. A payout past free cash flow draws the balance sheet down in every year it continues, which isn't sustainable indefinitely. Counting the $38M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 280%.
$668M
FY2023
Goodwill impairments.Took $668M of goodwill writedowns across 1 year (FY2023 ($668M)) — about 158% of net income over the span. A large writedown means an acquisition turned out worth far less than was paid — a real mark against M&A discipline.
-6%
FY2024→FY2025
Dividend — cut.The payout was CUT ~6% in FY2025 (from FY2024). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies.
Key fundamentals
Latest Revenue$6.85B
Revenue Growth YoY+1.9%
Revenue CAGR (2yr)+1.8%
Net Margin-11.4%
Free Cash Flow$227.0M
Return on Equity-4.2%
Debt / Equity0.23x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from DuPont De Nemours, Inc.'s actual 10-K/10-Q/8-K filings?